Biomarkers for epithelial-mesenchymal transitions
BPC-157 acts through multiple mechanisms, including VEGF-dependent and independent nitric oxide production, FAK-paxillin pathway activation, and gene expression modulation, without a single defined receptor
You may be a strong candidate for Epithalon therapy if you: Are interested in longevity and proactive aging support Experience fatigue, immune decline, or disrupted sleep Want to enhance cognitive clarity, stamina, or recovery Are seeking a science-backed anti-aging therapy without hormones or invasive procedures Want to support long-term cellular health and disease prevention Epithalon is often combined with other longevity-enhancing therapies such as CJC-1295 , NAD+ , and IV nutrient support for a comprehensive wellness strategy
M., Trellet, M., Schmitz, C., Kastritis, P